This blog will feature updates on activities of Prescription Access Litigation (PAL) and its members, including class action lawsuits, amicus curiae (Friend of the Court”) briefs, regulatory and legislative testimony and public education campaigns. We will also feature commentary on major developments and news stories on the pharmaceutical industry.
The PAL blog will not be updated daily, but rather as we have news to report. There are a number of daily pharmaceutical blogs that do a great job of covering the industry every day. See our blogroll on the left.
The universe of pharmaceutical blogs has grown rapidly over the past few months, as ably documented by John Mack over at PharmaBlogosphere. Some of its luminaries include industry critics and gadflies, such as Peter Rost and the pseudonymous Jack Friday (aka “Insider”). But as far as we have been able to ascertain, there are no other blogs critical of the industry that are written strictly from a consumer perspective. We hope to help partially fill that void.
So tune in, and stay tuned… We welcome your comments and suggestions.